Zydus Cadila’s vaccine candidate ZyCoV-D showed an immune response in animals like mice, guinea pigs, and rabbits, according to a pre-print of the company’s pre-clinical studies of the vaccine candidate.“...these initial results demonstrate the immunogenicity of our ZyCoV-D DNA vaccine candidate in multiple animal models.
These studies strongly support the clinical evaluation as a vaccine candidate for COVID-19 infection," the pre-print showed.The results from pre-clinical studies, which have not yet been peer-reviewed, were the first results that Zydus Cadila has published for its covid-19 vaccine candidate ZyCoV-D.The researchers evaluated the immunogenicity potential of Zydus’ plasmid DNA vaccine candidate in mice, guinea pig, and rabbit.